SHEN Feihan 1 , LUO Qiyin 2 , YANG Zhenzhen 3 , ZHANG Yajie 3 , GUO Ni 3 , LOU Wenhui 4 , SONG Xuping 3 , YANG Kehu 3 , White Howard 5,6,7,8
  • 1. Gansu Provincial Hospital, Lanzhou 730000, P. R. China;
  • 2. Chengdu Blood Center, Chengdu 610041, P. R. China;
  • 3. Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
  • 4. The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, P. R. China;
  • 5. Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 6. Center for Evidence-based Social Science, School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
  • 7. Innovation Laboratory of Evidence-based Social Science, Lanzhou University, Lanzhou 730000, P. R. China;
  • 8. The Research and Evaluation Centre, London SE92TF, UK;
SONG Xuping, Email: songxp@lzu.edu.cn; YANG Kehu, Email: yangkh@lzu.edu.cn
Medical consumables; Centralized volume-based procurement (CVBP); Patients' hospitalization expenses; Systematic review; Meta-analysis
10.7507/1672-2531.202507122
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective  To systematically review the impact of the centralized volume-based procurement (CVBP) of medical consumables on patients' hospitalization expenses in China. Methods  The PubMed, Web of Science Core Collection, Scopus, CNKI, CBM, and WangFang Data were electronically searched to collect studies on the impact of CVBP medical consumables on patients' hospitalization expenses from Jan 1, 2000 to May 13, 2025. Two researchers independently screened the literature, extracted data, and assessed the risk of bias of the included studies. Meta-analysis was then performed using Stata 17.0 software. Results  The meta-analysis showed that the implementation of the CVBP policy for medical consumables significantly reduced the average patient hospitalization expense (SMD=?4.754, 95%CI ?7.434 to ?2.075, P<0.001). Subgroup analysis indicated that the average patient hospitalization expense decreased after CVBP of coronary stents (SMD=?0.721, 95%CI ?1.040 to ?0.402, P<0.001) and intraocular lenses (SMD=?0.660, 95%CI ?0.984 to ?0.337, P<0.001), with the largest reduction observed after the procurement of artificial joints (SMD=?10.344, 95%CI ?15.147 to ?5.540, P<0.001). Conclusion  Evidence from evaluations of the CVBP from the patient's perspective in China is mainly concentrated in developed provinces and cities. Moderate-quality evidence suggests that the largest reduction in average patients' hospitalization expenses occurred after the CVBP of artificial joints, followed by coronary stents and intraocular lenses. It is recommended to further expand the scope of CVBP in the future in China.

Copyright ? the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved